Translation, Cross-cultural Adaptation, Reliability, Validity and Responsiveness of Short Form 36 (SF-36) Questionnaire in Stroke Survivors
RVR
1 other identifier
observational
125
1 country
1
Brief Summary
The type of the study is an observational study to test in stroke survivors. The main questions it aims to answer are
- 1.What is a Burmese version, content validity, convergent validity, divergent validity, and reliability of SF-36 questionnaire in stroke survivors?
- 2.Does the Burmese version of SF-36 have the responsiveness in stroke survivors? Participants will be interviewed the questionnaire by the research team.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedStudy Start
First participant enrolled
December 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedMarch 6, 2024
March 1, 2024
1 year
December 1, 2023
March 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Short Form 36
Short Form 36 (SF-36) is a generic self-reported outcome measure that quantifies the quality of life in relation to health status. It is a 36-item valid and reliable evaluation with eight areas covering physical functioning, role limitations brought on by physical issues, bodily pain, general health perceptions, vitality, social functioning, role limitations brought on by emotional issues, and perceived mental health. The SF-36 also contains a single question called "health transition" that measures how respondents feel their over health status has changed over the course of a year. The scores range from 0-100 (the worst possible to the most possible) (Ware \& Sherbourne, 1992).
Baseline-1 week-4th week
Secondary Outcomes (4)
Patient Reported Outcome Measurement System (PROMIS-29)
Baseline-1 week
Berg Balance Scale (BBS)
Baseline-1 week
Barthel Index (BI)
Baseline-1 week
Global Rating of Change (GRC) Scale
Baseline-1 week-4th week
Study Arms (1)
patients with hemiplegia
The intervention program will be based on usual care physiotherapy treatment in a hospital setting. It will be given 3 times per day, 5 days per week for 4 weeks duration.
Interventions
The training program used in this study is the stroke rehabilitation program focusing on health education for stroke and a routine exercise program based on the National Strategic Plan for Stroke Rehabilitation in Myanmar.
Eligibility Criteria
Hemiplegic patients who will be treated at inpatient ward of Department of Physical Medicine and Rehabilitation
You may qualify if:
- Age 18 years and above (Coppers et al., 2021; Soto-Vidal et al., 2021; Wayessa et al., 2023)
- Hemiplegia induced by both ischemic and hemorrhagic stroke at least 1 month duration (Wayessa et al., 2023; Vincent-Onabajo, Owolabi \& Hamzat, 2014)
- Ability to understand the study and respond to questions (on the Mini- Mental State Examination \> 23) (Wongchaisuwan et al., 2005; Muangpaisan et al., 2015)
- Stable medical conditions
You may not qualify if:
- Other neurological diseases such as Parkinson's disease, dementia, Alzheimer's disease, peripheral neuropathy according to medical history and record
- Recurrent stroke
- Participants with dysphasia, intellectual impairments, traumatic head injury, and psychiatric diseases (Wayessa et al., 2023)
- \) Participants who cannot understand Burmese language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yangon General Hospital
Yangon, 11131, Burma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Myitzu Khin Khin, Master
Khon Kaen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 1, 2023
First Posted
December 11, 2023
Study Start
December 30, 2023
Primary Completion
December 30, 2024
Study Completion
December 30, 2024
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 1 year after publication
IPD and documents will be available for sharing 1 year after publication for a period of 2 years. Access to the IPD and documents will be open on the IPDShare website with registration.